Document is current
Any future updates will be listed below
-
Authors
Sevilla, Lisa M.
Pons-Alonso, Omar http://orcid.org/0000-0002-4753-1082
Gallego, Andrea
Azkargorta, Mikel
Elortza, Félix
Pérez, Paloma http://orcid.org/0000-0002-7166-2824
- License Information
-
More Information
Article History
Received: 26 January 2024
Revised: 16 July 2024
Accepted: 18 July 2024
First Online: 28 July 2024
Competing interests
: The authors declare no competing interests.
: The use of human keratinocytes in monolayer and epidermal equivalents, and lentiviral infections were performed at IBV-CSIC facilities A/ES/21/I-06 (approval A/ES/21/112). Skin biosies from AD patients (<i>n</i> = 2) and healthy individuals (<i>n</i> = 2), who gave written informed consent, were collected, processed and provided by the Biobank Network (BIOBANC-MUR; national registration number B.0000859) in Murcia, Spain, and were processed following standard operating procedures with appropriate approval of the Ethical and Scientific Committees and in accordance with the Declaration of Helskinki.
